Download PDF
CC BY-NC-ND 4.0 · Sleep Sci 2018; 11(04): 254-259
DOI: 10.5935/1984-0063.20180040
ORIGINAL ARTICLE

Patients' preferences and the efficacy of a hybrid model of a minimal contact nasal mask in patients with sleep apnea treated with CPAP

Magali Blanco
1   Hospital Británico de Buenos Aires, Sleep Units - Buenos Aires City - Buenos Aires - Argentina.
,
Veronica Jaritos
2   Hospital de Clínicas José de San Martín, Sleep Units - Buenos Aires City - Buenos Aires - Argentina.
,
Glenda Ernst
1   Hospital Británico de Buenos Aires, Sleep Units - Buenos Aires City - Buenos Aires - Argentina.
,
Alejandro Salvado
1   Hospital Británico de Buenos Aires, Sleep Units - Buenos Aires City - Buenos Aires - Argentina.
,
Facundo Nogueira
2   Hospital de Clínicas José de San Martín, Sleep Units - Buenos Aires City - Buenos Aires - Argentina.
,
Eduardo Borsini
1   Hospital Británico de Buenos Aires, Sleep Units - Buenos Aires City - Buenos Aires - Argentina.
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Objectives To evaluate patient's satisfaction, efficacy and adherence to CPAP with a hybrid nasal mask (DW) we tested patients with OSA in unattended setting under real-life conditions.

Material and Methods Prospective, comparative study using DW mask 7 days against habitual mask in patients adapted to CPAP therapy.

Results We analyzed 52 patients: 35 men (67%) with IAH mean; 24.3±12.3 events/hour. At baseline mean compliance of 5.42±1.83 hours/night. After using DW mask, patients reported fewer marks, more comfort, greater partners acceptance, easier to use and was ranked higher to preventing leaks; p<0.05, and adherence (1 more hour per night,p>0.0042).Differences were not found in pressure 90th-95th percentile (9.6±9.2 cm of H2O, p<0.5), leaks (19.8±17 liters/min. p<0.37) or residual AHI (3.38±3.05 events/hour. p<0.93).

Conclusion In an uncontrolled non-randomized study, patients can use DW mask with similar leak level and better adherence as compared to conventional masks.

Treatment Adherence and Compliance - Continuous Positive Airway Pressure - Monitoring - Sleep Apnea Syndromes


Publication History

Received: 05 May 2018

Accepted: 24 August 2018

Article published online:
16 October 2023

© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • REFERENCES

  • 1 Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217-39.
  • 2 Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med. 2010;11(5):441-6.
  • 3 Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365(9464):1046-53.
  • 4 Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, et al.; American Academy of Sleep Medicine. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006;29(3):375-80.
  • 5 Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airway pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;(3):CD001106.
  • 6 McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al.; SAVE Investigators and Coordinators. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. N Engl J Med. 2016;375(10):919-31.
  • 7 Haniffa M, Lasserson TJ, Smith I. Interventions to improve compliance with continuous positive airway pressure for obstructive sleep apnoea. Cochrane Database Syst Rev. 2004;(4):CD003531.
  • 8 Meurice JC, Ingrand P, Portier F, Arnulf I, Rakotonanahari D, Fournier E, et al.; ANTADIR Working Group “PPC”, CMTS ANTADIR. A multicentre trial of education strategies at CPAP induction in the treatment of severe sleep apnoea-hypopnoea syndrome. Sleep Med. 2007;8(1):37-42.
  • 9 Billings ME, Auckley D, Benca R, Foldvary-Schaefer N, Iber C, Redline S, et al.; Race and residential socioeconomics as predictors of CPAP adherence. Sleep. 2011;34(12):1653-8.
  • 10 Kohler M, Smith D, Tippett V, Stradling JR. Predictors of long-term compliance with continuous positive airway pressure. Thorax. 2010;65(9):829-32.
  • 11 Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc. 2008;5(2):173-8.
  • 12 Ayas NT, FitzGerald JM, Fleetham JA, White DP, Schulzer M, Ryan CF, et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med. 2006;166(9):977-84.
  • 13 Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993;147(4):887-95.
  • 14 Olsen KD, Kern EB, Westbrook PR. Sleep and breathing disturbances secondary to nasal obstruction. Otolaryngol Head Neck Surg. 1981;89(5):804-10.
  • 15 Andrade RG, Piccin VS, Nascimento JA, Viana FM, Genta PR, Lorenzi- Filho G. Impact of the type of mask on the effectiveness of and adherence to continuous positive airway pressure treatment for obstructive sleep apnea. J Bras Pneumol. 2014;40(6):658-68.
  • 16 Andrade RGS, Viana FM, Nascimento JA, Drager LF, Moffa A, Brunoni AR, et al. Nasal vs Oronasal CPAP for OSA Treatment: A Meta-Analysis. Chest. 2018;153(3):665-74.
  • 17 Borel JC, Tamisier R, Dias-Domingos S, Sapene M, Martin F, Stach B, et al.; Scientific Council of The Sleep Registry of the French Federation of Pneumology (OSFP). Type of mask may impact on continuous positive airway pressure adherence in apneic patients. PLoS One. 2013;8(5):e64382.
  • 18 Ebben MR, Oyegbile T, Pollak CP. The efficacy of three different mask styles on PAP titration night. Sleep Med. 2012;13(6):645-9.
  • 19 Bachour A, Vitikainen P, Virkkula P, Maasilta P. CPAP interface: satisfaction and side effects. Sleep Breath. 2013;17(2):667-72.
  • 20 Schorr F, Genta PR, Gregório MG, Danzi-Soares NJ, Lorenzi-Filho G. Continuous positive airway pressure delivered by oronasal mask may not be effective for obstructive sleep apnoea. Eur Respir J. 2012;40(2):503-5.
  • 21 Genta PR, Eckert DJ, Gregorio MG, Danzi NJ, Moriya HT, Malhotra A, et al. Critical closing pressure during midazolam-induced sleep. J Appl Physiol (1985). 2011;111(5):1315-22.
  • 22 Rabec C, Georges M, Kabeya NK, Baudouin N, Massin F, Reybet- Degat O, et al. Evaluating noninvasive ventilation using a monitoring system coupled to a ventilator: a bench-to-bedside study. Eur Respir J. 2009;34(4):902-13.
  • 23 Lanza A, Mariani S, Sommariva M, Campana C, Rubino A, Nichelatti M, et al. Continuous positive airway pressure treatment with nasal pillows in obstructive sleep apnea: long-term effectiveness and adherence. Sleep Med. 2018;41:94-9.
  • 24 Dibra MN, Berry RB, Wagner MH. Treatment of Obstructive Sleep Apnea: Choosing the Best Interface. Sleep Med Clin. 2017;12(4):543-9.